Innovative therapies and unique solutions

Solving the un(dis)solvable

We research and develop pioneering technology platforms that pave the way for innovative therapies to treat respiratory and ophthalmic conditions. We devise new patents, brands and products on the basis of scientific ideas.

Marinosolv® platform clinically validated

About us

Marinomed is a biopharmaceutical company that develops innovative products to treat respiratory and ophthalmic conditions on the basis of patent protected technology platforms. As well as working on research and development, Marinomed is already generating revenues from the Carragelose® platform and the sale of its products. With the successful completion of the Phase III study for its flagship product Budesolv, Marinomed achieved the decisive breakthrough for its promising Marinosolv® platform in 2019.

Technology platforms

Where to meet us

CPhI Worldwide

November 5-7, 2019 Frankfurt, Germany


November 7-11, 2019 Houston, TX


November 11-13, 2019 Hamburg, Germany


December 12-14, 2019 Lyon, France


Product Launches